Nikola Panayot Pavletich is the former chair of structural biology at Memorial Sloan Kettering Cancer Center.[1]

Education

edit

Pavletich received his BS in chemistry from Caltech in 1988 and his PhD in molecular biology and genetics from Johns Hopkins University School of Medicine in 1991.[2] He did a postdoc at MIT with Carl Pabo.

Career

edit

He joined the faculty at Sloan Kettering in 1993 and was named chair of the Structural Biology Program in 2003.[3] He has been an HHMI investigator since 1997.

His laboratory researches malignant cell growth and DNA damage contributing to the development of cancer. DNA damage repair is a significant factor in whether a cell will become cancerous after genetic insult. Some of his major focuses have been the mTOR pathway and BRCA1. His lab uses x-ray crystallography to determine how proteins interact.[4][3]

Awards

edit

References

edit
  1. ^ "The Nikola Pavletich Lab - Memorial Sloan Kettering Cancer Center". www.mskcc.org. December 2020.
  2. ^ "Nikola Pavletich, PhD - Tri-Institutional PhD Program in Chemical Biology".
  3. ^ a b c "Two Memorial Sloan Kettering Investigators Named to National Academy of Sciences - Gerstner Sloan Kettering Graduate School of Biomedical Sciences". www.sloankettering.edu. 30 May 2012.
  4. ^ "Nikola P. Pavletich, PhD Research Abstract - HHMI.org".
  5. ^ "Nikola P. Pavletich, Ph.D." www.pewtrusts.org.
  6. ^ "Nikola P. Pavletich". Arnold and Mabel Beckman Foundation. Retrieved 1 August 2018.
  7. ^ Review, MIT Technology. "Innovator Under 35: Nikola Pavletich, 33". MIT Technology Review.
  8. ^ https://www.amacad.org/multimedia/pdfs/alphalist2014.pdf [bare URL PDF]
  9. ^ "National Academy of Medicine Elects New Members - The ASCO Post". www.ascopost.com.